What is AKTS's dilution risk score?

AKTS has a latest available DilutionScore record of 43/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for AKTS, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for AKTS?

DilutionWatch tracks 25 SEC filing types for AKTS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect AKTS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For AKTS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for AKTS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for AKTS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

AKTS Dilution Risk Score: 43/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

35

💰 Cash Runway

25

📊 Float Risk

45

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for AKTS.

🔔 Track AKTS — Get forecast alerts →

Market Data

Market Cap$1.15B

Shares Outstanding53.45M

Float28.15M

Cash$82.49M

Debt$11.58M

Short InterestN/A

Institutional Holdings

2 institutional holders · 285.9K shares

#1 BARCLAYS PLC 258.1K shares

#2 Kohmann Bosshard Financial Services, LLC 27.8K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.47M

Days to Cover12.8

% of Float12.3%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-31

4 INSIDER TRANSACTION 2026-04-16

3 FORM3 2026-04-16

3 FORM3 2026-01-15

4 INSIDER TRANSACTION 2026-01-14

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual AKTS Dilution Snapshot

Aktis Oncology, Inc. (AKTS) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for AKTS: 4 on 2026-04-16; 3 on 2026-04-16; xbrl on 2026-03-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.